What is the classification of gallbladder (Ca GB) cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gallbladder Cancer Classification

Gallbladder cancer is classified using the TNM staging system, with the AJCC/UICC 7th edition (or newer 8th edition) being the standard classification that stratifies patients based on depth of tumor invasion (T), regional lymph node involvement (N), and distant metastases (M). 1

TNM Classification System

Primary Tumor (T) Classification

The T stage is determined by the depth of invasion into the gallbladder wall and adjacent structures 2, 1:

  • Tis: Carcinoma in situ 2
  • T1a: Tumor invades lamina propria only 2, 1
  • T1b: Tumor invades muscular layer 2, 1
  • T2: Tumor invades perimuscular connective tissue with no extension beyond serosa or into liver 2, 1
  • T3: Tumor perforates the serosa and/or directly invades the liver and/or one other adjacent organ or structure 2, 1
  • T4: Tumor invades main portal vein or hepatic artery, or invades two or more extrahepatic organs or structures 1

The 8th edition UICC classification further subdivides T2 into T2a (tumor invades perimuscular connective tissue on peritoneal side without serosal involvement) and T2b (tumor invades perimuscular connective tissue on hepatic side without liver invasion), which effectively stratifies prognosis within T2 disease 3.

Regional Lymph Node (N) Classification

The N stage categorizes lymph node involvement 2, 1:

  • N0: No regional lymph node metastasis 2
  • N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein 2, 1
  • N2: Metastases to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes 2, 1

Lymph node involvement is present in 50% of patients at presentation and strongly predicts poor surgical outcomes 1, 4. The cystic, pericholedochal, and posterosuperior peripancreatic nodes are the most prevalent sites of metastasis and should be considered key nodes for lymphatic spread 5.

Distant Metastasis (M) Classification

  • M0: No distant metastasis 2
  • M1: Distant metastasis present 2

Peritoneal and distant metastases are present in 10-20% of patients at presentation, representing stage IVB disease 1, 4.

Stage Grouping

The TNM components are combined into overall stages (I-IV), with each stage having distinct prognostic implications 2, 1. The 8th edition AJCC staging system has been validated to effectively stratify survival, with significant differences between stages I through IV 3.

Required Staging Workup

Complete staging must include 2, 1, 4:

  • Complete history and physical examination
  • Blood counts and liver function tests
  • Chest X-ray for pulmonary metastases
  • Abdominal imaging with CT scan or MRI
  • Endoscopic retrograde or percutaneous transhepatic cholangiography when indicated
  • Endoscopic ultrasonography for local staging
  • Laparoscopy to determine presence of peritoneal or superficial liver metastases 1, 4

Clinical Pitfalls and Considerations

Precise preoperative T staging is challenging, with diagnostic accuracy of only 52.6%, particularly for early-stage disease (T1 and T2 showing 37.2% and 33.9% accuracy respectively) 5. However, preoperative imaging-based T classification (image-T) remains a significant predictor of lymph node metastasis and patient outcome 5.

Preoperative N staging is even more difficult, with only 24.5% of node-positive patients correctly diagnosed preoperatively 5. Intraoperative histopathologic examination of key lymph nodes combined with image-T classification provides the most accurate staging before definitive resection 5.

For optimal prognostic assessment in node-positive patients, at least 6 lymph nodes should be retrieved and examined, as this threshold significantly influences staging quality and survival 6. Both total lymph node count (TLNC) and lymph node ratio (LNR) are strong independent predictors of disease-specific survival 6.

References

Guideline

Gallbladder Cancer Staging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Gallbladder Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.